相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CAR T cells produced in vivo to treat cardiac injury
Joel G. Rurik et al.
SCIENCE (2022)
Rituximab in patients with acute ST-elevation myocardial infarction: an experimental medicine safety study
Tian X. Zhao et al.
CARDIOVASCULAR RESEARCH (2022)
Colchicine prevents disease progression in viral myocarditis via modulating the NLRP3 inflammasome in the cardiosplenic axis
Kathleen Pappritz et al.
ESC HEART FAILURE (2022)
Novel strategies for the mitigation of cytokine release syndrome induced by T cell engaging therapies with a focus on the use of kinase inhibitors
Gabrielle Leclercq et al.
ONCOIMMUNOLOGY (2022)
TET2-Driven Clonal Hematopoiesis and Response to Canakinumab An Exploratory Analysis of the CANTOS Randomized Clinical Trial
Eric C. Svensson et al.
JAMA CARDIOLOGY (2022)
Clinical trials for chimeric antigen receptor T-cell therapy: lessons learned and future directions
Brett A. Schroeder et al.
CURRENT OPINION IN HEMATOLOGY (2022)
Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy
Emma C. Morris et al.
NATURE REVIEWS IMMUNOLOGY (2022)
Myocarditis and inflammatory cardiomyopathy: current evidence and future directions
Carsten Tschoepe et al.
NATURE REVIEWS CARDIOLOGY (2021)
Cigarette smoke extract induces pyroptosis in human bronchial epithelial cells through the ROS/NLRP3/caspase-1 pathway
Meng-Yu Zhang et al.
LIFE SCIENCES (2021)
Microenvironmental IL-6 inhibits anti-cancer immune responses generated by cytotoxic chemotherapy
Eric H. Bent et al.
NATURE COMMUNICATIONS (2021)
Cancer-A Major Cardiac Comorbidity With Implications on Cardiovascular Metabolism
Daniel Finke et al.
FRONTIERS IN PHYSIOLOGY (2021)
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
Paul M. Ridker et al.
LANCET (2021)
Immune Cells and Immunotherapy for Cardiac Injury and Repair
Joel G. Rurik et al.
CIRCULATION RESEARCH (2021)
Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial
Jean-Claude Tardif et al.
LANCET RESPIRATORY MEDICINE (2021)
Tumor NLRP3-Derived IL-1β Drives the IL-6/STAT3 Axis Resulting in Sustained MDSC-Mediated Immunosuppression
Isak W. Tengesdal et al.
FRONTIERS IN IMMUNOLOGY (2021)
The Role of NLRP3 Inflammasome in Pericarditis
Adolfo G. Mauro et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2021)
Heart failure as interstitial cancer: emergence of a malignant fibroblast phenotype
Kelsie E. Oatmen et al.
NATURE REVIEWS CARDIOLOGY (2020)
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
Rita Cabrita et al.
NATURE (2020)
B cells and tertiary lymphoid structures promote immunotherapy response
Beth A. Helmink et al.
NATURE (2020)
Tocilizumab for refractory severe immune checkpoint inhibitor-associated myocarditis
J. Doms et al.
ANNALS OF ONCOLOGY (2020)
S100A9 Links Inflammation and Repair in Myocardial Infarction
Goran Marinkovic et al.
CIRCULATION RESEARCH (2020)
Reverse Cardio-Oncology: Cancer Development in Patients With Cardiovascular Disease
Joseph Pierre Aboumsallem et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Serum alarmin S100A8/S100A9 levels and its potential role as biomarker in myocarditis
Irene Mueller et al.
ESC HEART FAILURE (2020)
Early Cardiac Remodeling Promotes Tumor Growth and Metastasis
Shimrit Avraham et al.
CIRCULATION (2020)
Inflammasome genetics and complex diseases: a comprehensive review
Fernanda Pereira Fernandes et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2020)
Involvement of ROS/NLRP3 Inflammasome Signaling Pathway in Doxorubicin-Induced Cardiotoxicity
Shanshan Wei et al.
CARDIOVASCULAR TOXICOLOGY (2020)
NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword
Shaima'a Hamarsheh et al.
FRONTIERS IN IMMUNOLOGY (2020)
The role of B cells in heart failure and implications for future immunomodulatory treatment strategies
Gerardo Garcia-Rivas et al.
ESC HEART FAILURE (2020)
Myocardial infarction accelerates breast cancer via innate immune reprogramming
Emma M. Corr et al.
NATURE MEDICINE (2020)
Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies
Valerio Gelfo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Development of Cancer in Patients With Heart Failure: How Systemic Inflammation Can Lay the Groundwork
Simonetta Ausoni et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
Blocking the IL-1 signalling pathway prevents chronic viral myocarditis and cardiac remodeling
Lisa Kraft et al.
BASIC RESEARCH IN CARDIOLOGY (2019)
Inflammation: a common contributor to cancer, aging, and cardiovascular diseasesexpanding the concept of cardio-oncology
Peter Libby et al.
CARDIOVASCULAR RESEARCH (2019)
Phase II clinical trial testing the safety of a humanised monoclonal antibody anti-CD20 in patients with heart failure with reduced ejection fraction, ICFEr-RITU2: study protocol
Luis Sanchez-Trujillo et al.
BMJ OPEN (2019)
Management of Myocarditis-Related Cardiomyopathy in Adults
Carsten Tschoepe et al.
CIRCULATION RESEARCH (2019)
NLRP3 inhibitors stoke anti-inflammatory ambitions
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2019)
Impact of B-Cell-Targeted Therapies on Cardiovascular Disease
Florentina Porsch et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Accelerated Allograft Vasculopathy With Rituximab After Cardiac Transplantation
Randall C. Starling et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
The Quest for Antiinflammatory and Immunomodulatory Strategies in Heart Failure
Sophie Van Linthout et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Jean-Claude Tardif et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
NLRP3 inflammasome in fibroblasts links tissue damage with inflammation in breast cancer progression and metastasis
Nour Ershaid et al.
NATURE COMMUNICATIONS (2019)
Bidirectional effects of IL-10+ regulatory B cells in Ldlr-/- mice
Hidde Douna et al.
ATHEROSCLEROSIS (2019)
Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure
Brendan M. Everett et al.
CIRCULATION (2019)
Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation
Irena Kaplanov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies
Nikolaus B. Wagner et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Targeting CD20+B-lymphocytes in inflammatory dilated cardiomyopathy with rituximab improves clinical course: a case series
Carsten Tschope et al.
EUROPEAN HEART JOURNAL-CASE REPORTS (2019)
Treg gene signatures predict and measure type 1 diabetes trajectory
Anne M. Pesenacker et al.
JCI INSIGHT (2019)
Diverging inflammasome signals in tumorigenesis and potential targeting
Rajendra Karki et al.
NATURE REVIEWS CANCER (2019)
Heart Failure Stimulates Tumor Growth by Circulating Factors
Wouter C. Meijers et al.
CIRCULATION (2018)
Cardiovascular Disease and Breast Cancer: Where These Entities Intersect A Scientific Statement From the American Heart Association
Laxmi S. Mehta et al.
CIRCULATION (2018)
CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade
Theodoros Giavridis et al.
NATURE MEDICINE (2018)
Innate and adaptive immunity in atherosclerosis
Kapka Miteva et al.
VASCULAR PHARMACOLOGY (2018)
Past, Present, and Future of Rituximab-The world's First Oncology Monoclonal Antibody Therapy
Timothy M. Pierpont et al.
FRONTIERS IN ONCOLOGY (2018)
Linking Heart Failure to Cancer: Background Evidence and Research Perspectives
Edoardo Bertero et al.
CIRCULATION (2018)
Inflammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis
Si Ming Man
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
Paul M. Ridker et al.
LANCET (2017)
Targeting Inflammation in Coronary Artery Disease
Robert A. Harrington
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
S. Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
Jose J. Fuster et al.
SCIENCE (2017)
Interleukin 6 Inhibition and Coronary Artery Disease in a High-Risk Population: A Prospective Community-Based Clinical Study
Bruno Cesar Bacchiega et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Lung Cancer and Risk of Cardiovascular Disease: A Meta-analysis of Cohort Studies
Min Yuan et al.
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2017)
Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis
Irene Mueller et al.
CIRCULATION-HEART FAILURE (2017)
NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis
Carsten Tschoepe et al.
CIRCULATION-HEART FAILURE (2017)
Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes
Catherine C. Coombs et al.
CELL STEM CELL (2017)
Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly
Florian Zink et al.
BLOOD (2017)
Incidence of cancer in patients with chronic heart failure: a long-term follow-up study
Ann Banke et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Cardiovascular Disease Among Survivors of Adult-Onset Cancer: A Community-Based Retrospective Cohort Study
Saro H. Armenian et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
The Effects of Rituximab on Lipids, Arterial Stiffness, and Carotid Intima-Media Thickness in Rheumatoid Arthritis
Diana S. Novikova et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2016)
Role of Inflammasome Genetics in Susceptibility to HPV Infection and Cervical Cancer Development
A. Pontillo et al.
JOURNAL OF MEDICAL VIROLOGY (2016)
Leukocytes Link Local and Systemic Inflammation in Ischemic Cardiovascular Disease An Expanded Cardiovascular Continuum
Peter Libby et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Precision medicine in cardiology
Elliott M. Antman et al.
NATURE REVIEWS CARDIOLOGY (2016)
Regulatory B Cell-Specific Interleukin-10 Is Dispensable for Atherosclerosis Development in Mice
Andrew P. Sage et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
B-1b Cells Secrete Atheroprotective IgM and Attenuate Atherosclerosis
Sam M. Rosenfeld et al.
CIRCULATION RESEARCH (2015)
The Nlrp3 Inflammasome Suppresses Colorectal Cancer Metastatic Growth in the Liver by Promoting Natural Killer Cell Tumoricidal Activity
Jeremy Dupaul-Chicoine et al.
IMMUNITY (2015)
Pharmacologic Inhibition of the NLRP3 Inflammasome Preserves Cardiac Function After Ischemic and Nonischemic Injury in the Mouse
Carlo Marchetti et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2015)
Colchicine Significantly Reduces Incident Cancer in Gout Male Patients A 12-Year Cohort Study
Ming-Chun Kuo et al.
MEDICINE (2015)
Context-dependent role of IL-18 in cancer biology and counter-regulation by IL-18BP
Marina Fabbi et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
The Impact of Newer Biological Disease Modifying Anti-Rheumatic Drugs on Cardiovascular Risk Factors: A 12-Month Longitudinal Study in Rheumatoid Arthritis Patients Treated with Rituximab, Abatacept and Tociliziumab
Sella Aarrestad Provan et al.
PLOS ONE (2015)
Interleukin-6 receptor inhibition modulates the immune reaction and restores titin phosphorylation in experimental myocarditis
Konstantinos Savvatis et al.
BASIC RESEARCH IN CARDIOLOGY (2014)
Mechanisms of action of tasquinimod on the tumour microenvironment
E. Raymond et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Innate Response Activator B Cells Aggravate Atherosclerosis by Stimulating T Helper-1 Adaptive Immunity
Ingo Hilgendorf et al.
CIRCULATION (2014)
Anti-inflammatory therapies for cardiovascular disease
Paul M. Ridker et al.
EUROPEAN HEART JOURNAL (2014)
Formation of the inflammasome in acute myocarditis
Stefano Toldo et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The NOD-Like Receptor Signalling Pathway in Helicobacter pylori Infection and Related Gastric Cancer: A Case-Control Study and Gene Expression Analyses
Natalia Castano-Rodriguez et al.
PLOS ONE (2014)
Alarmin S100A8/S100A9 as a biomarker for molecular imaging of local inflammatory activity
Thomas Vogl et al.
NATURE COMMUNICATIONS (2014)
Anti-Inflammatory Treatment With Colchicine in Stable Chronic Heart Failure A Prospective, Randomized Study
Spyridon Deftereos et al.
JACC-HEART FAILURE (2014)
Rituximab is associated with improved survival in cardiac allograft patients with antibody-mediated rejection: a single center review
Ashwin K. Ravichandran et al.
CLINICAL TRANSPLANTATION (2013)
TNF-α-Secreting B Cells Contribute to Myocardial Fibrosis in Dilated Cardiomyopathy
Miao Yu et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease
Stefan M. Nidorf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Patients With Heart Failure Have an Increased Risk of Incident Cancer
Tal Hasin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction
Yasmine Zouggari et al.
NATURE MEDICINE (2013)
Tumour inflammasome-derived IL-1ß recruits neutrophils and improves local recurrence-free survival in EBV-induced nasopharyngeal carcinoma
Lih-Chyang Chen et al.
EMBO MOLECULAR MEDICINE (2012)
Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis
Florian Leuschner et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Inflammasome Activation of Cardiac Fibroblasts Is Essential for Myocardial Ischemia/Reperfusion Injury
Masanori Kawaguchi et al.
CIRCULATION (2011)
Recombinant human interleukin-1 receptor antagonist protects mice against acute doxorubicin-induced cardiotoxicity
Jinzhou Zhu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
B cell depletion reduces the development of atherosclerosis in mice
Hafid Ait-Oufella et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Conventional B2 B Cell Depletion Ameliorates whereas Its Adoptive Transfer Aggravates Atherosclerosis
Tin Kyaw et al.
JOURNAL OF IMMUNOLOGY (2010)
Therapeutic antibodies for autoimmunity and inflammation
Andrew C. Chan et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis
Gyoergy Kerekes et al.
CLINICAL RHEUMATOLOGY (2009)
Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans
Meng-Yun Chou et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Common variants in the NLRP3 region contribute to Crohn's disease susceptibility
Alexandra-Chloe Villani et al.
NATURE GENETICS (2009)
Acute coronary syndromes complicating the first infusion of rituximab
Joel D. Armitage et al.
CLINICAL LYMPHOMA & MYELOMA (2008)
The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice
Y Hamaguchi et al.
JOURNAL OF IMMUNOLOGY (2005)
Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapy
Q Gong et al.
JOURNAL OF IMMUNOLOGY (2005)
分享论文
